Dr Hugh Hamilton Wilhite, MD in Calhoun, KY - Family Medicine

Dr Hugh Hamilton Wilhite, MD is a Family Medicine physician based in Calhoun, Kentucky. Dr Hugh Hamilton Wilhite is licensed to practice in Kentucky (license number 14534) and his current practice location is 145 E 2nd St, Calhoun, Kentucky. He can be reached at his office (for appointments etc.) via phone at (270) 273-3293.

NPI number for Dr Hugh Hamilton Wilhite is 1831276989 and his current mailing address is Po Box 23229, Owensboro, Kentucky. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1831276989.

Contact Information

	Dr Hugh Hamilton Wilhite, MD
	145 E 2nd St, Calhoun, KY 42327
	(270) 273-3293
	(270) 273-3294

Physician's Profile

Full Name	Dr Hugh Hamilton Wilhite
Gender	Male
Speciality	Family Medicine
Location	145 E 2nd St, Calhoun, Kentucky
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1831276989
Provider Enumeration Date: 11/01/2006
Last Update Date: 04/15/2016

Medical Identifiers

Medical identifiers for Dr Hugh Hamilton Wilhite such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1831276989	NPI	-	NPPES
64145345	Medicaid	KY

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	14534 (Kentucky)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Hugh Hamilton Wilhite is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Hugh Hamilton Wilhite, MD Po Box 23229, Owensboro, KY 42304-3229 Ph: (270) 688-1330	Dr Hugh Hamilton Wilhite, MD 145 E 2nd St, Calhoun, KY 42327 Ph: (270) 273-3293

News Archive

Moderate alcohol intake stimulates tumor angiogenesis and expression of vascular endothelial growth factor in a mouse model

University of Mississippi researchers say they have created the first-ever mammalian model of how alcohol consumption spurs tumor growth, showing that even moderate drinking resulted in larger and more robust tumors.

Lakewood-Amedex's novel class of antimicrobials prove effective at killing MDR-TB strains

Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains of Mycobacterium tuberculosis, the bacteria responsible for the chronic lung infection tuberculosis.

Clinical trial eligibility criteria may be excessive, needlessly excluding patients

Federal regulations may keep lung cancer patients out of clinical trials simply because these patients are on medications that might affect the electrical system of the heart. Drilling into the details quickly turns up reasons to think these regulations may be preventing a substantial proportion of patients from participating in clinical trials.

Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at ASTRO 2010

Celsion Corporation announced today that an abstract on the Phase I/II DIGNITY trial of ThermoDox in Recurrent Chest Wall Breast Cancer has been accepted for a poster session at the 52nd American Society for Radiation Oncology Annual Meeting. The abstract will provide updated clinical results, as well as the rationale and design of the DIGNITY study, which is evaluating ThermoDox in combination with microwave hyperthermia in women with RCW Breast Cancer.

CT angiography can replace digital subtraction angiography

CT angiography (CTA) alone is an effective, noninvasive means to detect peripheral vascular disease, according to a study conducted by researchers at Charite Campus Benjamin Franklin in Berlin, Germany.

Dr Hugh Hamilton Wilhite, MD - Family Medicine in Calhoun, KY